🚀 VC round data is live in beta, check it out!
Lidds Valuation Multiples
Discover revenue and EBITDA valuation multiples for Lidds and similar public comparables like Lipigon Pharmaceuticals, Oxurion, bioXXmed, Altamira Therapeutics and more.
Lidds Overview
About Lidds
Lidds AB is a Sweden-based drug delivery company focused on its proprietary NanoZolid technology platform. The NanoZolid system is used to formulate drugs for local administration with controlled and sustained release over extended periods. The company offers this technology to partners and is also developing its own pipeline of drug candidates, prominently in oncology, where the platform is used to enable localized and sustained drug delivery. It has a pipeline with several projects in clinical development, both in early- and late-stage clinical phases, and projects about to enter clinical development.
Founded
2003
HQ
Employees
6
Website
Sectors
Financials (FY)
Market Cap
$371K
Lidds Stock Performance
Lidds has current market cap of $371K.
Lidds' stock price is $0.00.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| $371K | 0.0% | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLidds Valuation Multiples
Lidds Financial Valuation Multiples
As of March 11, 2026, Lidds has market cap of $371K.
Equity research analysts estimate Lidds' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $371K | XXX | $371K | XXX | XXX | XXX |
| EV (current) | ($839K) | XXX | ($839K) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Lidds Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Lidds Public Comps
See public comps and valuation multiples for other Biopharmaceuticals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Lipigon Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| Oxurion | XXX | XXX | XXX | XXX | XXX | XXX |
| bioXXmed | XXX | XXX | XXX | XXX | XXX | XXX |
| Altamira Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| PCI Biotech Holding | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Lidds M&A Activity
Lidds acquired XXX companies to date.
Last acquisition by Lidds was on XXXXXXXX, XXXXX. Lidds acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Lidds
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialLidds Investment Activity
Lidds invested in XXX companies to date.
Lidds made its latest investment on XXXXXXXX, XXXXX. Lidds invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Lidds
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Lidds
| When was Lidds founded? | Lidds was founded in 2003. |
| Where is Lidds headquartered? | Lidds is headquartered in Sweden. |
| How many employees does Lidds have? | As of today, Lidds has over 6 employees. |
| Is Lidds publicly listed? | Yes, Lidds is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Lidds? | Lidds trades under LIDDS ticker. |
| When did Lidds go public? | Lidds went public in 2014. |
| Who are competitors of Lidds? | Lidds main competitors are Lipigon Pharmaceuticals, Oxurion, bioXXmed, Altamira Therapeutics. |
| What is the current market cap of Lidds? | Lidds' current market cap is $371K. |
| Is Lidds profitable? | No, Lidds is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.